Talk Precision Medicine
The Proteome Universe
Proteomics big data can help solve decision-making problems related to the diagnosis and treatment of prostate cancer.
03 / 01 / 2020 | Tiannan Guo
The most common cancer in men is often over-diagnosed and over-treated. The scientists at Westlake University have developed a mass spectrometry-based approach to fully characterize the proteome of tumor tissues, all in a single data record. Machine learning analysis can then clearly stratify cancer patients by survival probability using a protocol that can potentially be applied to various other diseases.
Tiannan Guo, MD, PhD
Principal Investigator
Guomics Laboratory for Proteomic Big Data, Westlake University
Director
iMarker lab, Westlake Laboratory
View profile
Featured products
Click any of the product images to learn more.
